PharmiWeb8d
Akribion Therapeutics exits from stealth with €8m seed financing to pioneer RNA-guided, programmable cell depletion
Financing led by CARMA FUND and RV Invest with participation of High-Tech Gründerfonds and others Akribion is pioneering a unique, RNA-guided, nuclease-based technology for programmable cell depletion ...
Deccan Chronicle11d
Malvika Poddar on Carma India's Foray Into Hyderabad
What’s the reason for Carma's expansion into Hyderabad, and how do you see the city’s fashion landscape evolving? Carma’s expansion into Hyderabad reflects the city’s growing appetite for ...
Yahoo Finance8d
Akribion Therapeutics exits from stealth with €8m seed financing to pioneer RNA-guided, programmable cell depletion
The round was led by CARMA FUND and RV Invest, with investments from MP Beteiligungs GmbH, Hessen Kapital I, Bruker Invest and High-Tech Gründerfonds. Lukas Linnig, Co-Founder and Co-CEO of ...
Yahoo Finance8d
Akribion Therapeutics exits from stealth with €8m seed financing to pioneer RNA-guided, programmable cell depletion
The round was led by CARMA FUND and RV Invest, with investments from MP Beteiligungs GmbH, Hessen Kapital I, Bruker Invest and High-Tech Gründerfonds. Lukas Linnig, Co-Founder and Co-CEO of Akribion ...
Business Insider14d
TYSON 2.0 and Carma HoldCo Expand Global Presence with Launch in South Africa
LAS VEGAS, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Carma HoldCo Inc, the global house of brands harnessing the power of cultural icons, announced the launch of TYSON 2.0 - legendary boxer, entrepreneur ...
The Pharma Letter8d
Akribion Therapeutics secures $9 million seed funding
The funding round was led by CARMA FUND and RV Invest, with additional contributions from MP Beteiligungs, Hessen Kapital I, Bruker Invest, and High-Tech Gründerfonds. Akribion is developing a new ...